Altamira Therapeutics (CYTO) to Release Earnings on Tuesday

Altamira Therapeutics (NASDAQ:CYTO) will issue its quarterly earnings data before the market opens on Tuesday, September 24th. Parties that wish to register for the company’s conference call can do so using this link.

Altamira Therapeutics Price Performance

Shares of Altamira Therapeutics stock opened at $0.71 on Monday. The firm has a 50 day simple moving average of $0.99 and a 200 day simple moving average of $1.37. Altamira Therapeutics has a fifty-two week low of $0.71 and a fifty-two week high of $17.20.

About Altamira Therapeutics

Altamira Therapeutics Ltd. operates as a preclinical-stage biopharmaceutical company in Switzerland and Australia. The company develops and supplies OligoPhore/SemaPhore platforms, which are peptide-based nanoparticle technologies for ribonucleic acid delivery to extrahepatic tissues. Its commercial products include Bentrio, a drug-free nasal spray for personal protection against airborne viruses and allergens.